Log In
Print
BCIQ
Print
Print this Print this
 

AC-201

  Manage Alerts
Collapse Summary General Information
Company TWi Pharmaceuticals Holding Inc.
DescriptionSmall molecule that modulates the transcription of IL-1 beta and IL-1RA
Molecular Target Interleukin-1 (IL-1) beta ; Interleukin-1 (IL-1) receptor antagonist (IL-1RA)
Mechanism of ActionInducible nitric oxide synthase (iNOS) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today